🚀
Enjoy a 7-Day Free Trial Thru May 01, 2024!
✨
Sign Up
Login
Free Sign-up
Login
7-Day Free Trial
Home
Homepage
Membership Levels
About Us
General Discussion
Complete Stock List
The book
Membership Data Coverage
Founder's Message
Free Trial
Referral Program
Partner Program
GuruFocus Podcast
Screeners
GuruFocus Screeners
All-In-One Screener
Ben Graham Lost Formula
Canadian Faster Growers
CEO Buys
CEO Buys after Price Drop > 20%
Dividend Kings 2023
Dividend Aristocrats 2023
Dividend Growth Portfolio
Dividend Income Portfolio
Fast Growers
Good Companies
Hedge Fund Guru Top 10 Aggregated
High Quality
High Quality Low Capex w ROE ROC min
High Quality & Low Capex
High Yield Insider Buys
Historical High Dividend Yields
International Gurus' Top Holdings
James Montier Short Screen
Margin Decliners
Mega Caps
Peter Lynch & Warren Buffett
Peter Lynch Growth w Lower Valuation
Peter Lynch S&L Traded Below Book
PFCF Screener
Piotroski Score Screener
Predictable Growth Companies
Profitable predictable margin expanders
Stocks Sold w less Cash
The Stalwarts
My Screeners
Create My Screener
Value Screens
Stock Ideas
All-In-One Screener
S&P 500 Map
S&P 500 Bubble
S&P 500 Aggregate
Buffett-Munger Screener
Industry Overview
Undervalued Predictable
Benjamin Graham Net-Net
52-week/3Y/5Y Lows
52-week/3Y/5Y Highs
Magic Formula(Greenblatt)
Dividend Stocks
Peter Lynch Screen
S&P500 Grid
Predictable Companies
Spin Off List
Merger and Acquisition List
Historical Low P/B List
Historical Low P/S List
High Short Interest
Upcoming Special Dividends
Delisted Stocks
Model Portfolios
Performances Overview
Most Broadly Held Portfolio
Most Weighted Portfolio
Buffett-Munger Top 25
GF Score <= 100 Top 25
Top 25 Undervalued Predictable
Top 25 52-week Low Predictable
Top 25 Historical Low P/S
Stock Comparison
Airline Stocks
Artificial Intelligence Stocks
Bank Stocks
Biotech Stocks
Blockchain Stocks
Chinese Stocks
Dividend Stocks
EV Stocks
Growth Stocks
Oil Stocks
Value Stocks
Virtual Reality Stocks
Compare More Stocks…
Gurus
Guru Trades
Latest Guru Picks
Real Time Picks
Guru Portfolio
Score Board
Mutual Funds
Top 10 Holdings
Sector Picks
International Picks
Aggregated Portfolio
Consensus Picks
Guru Bargains
Hot Picks
Download Guru Portfolios
Industry Trends
Geographic Trend
ETFs
Options Holdings
European Shorting
Guru Lists
Complete Guru List
Warren Buffett
Bill Gates
Mohnish Pabrai
Carl Icahn
George Soros
David Tepper
Seth Klarman
Bill Ackman
Joel Greenblatt
Charlie Munger
Michael Price
Julian Robertson
Chuck Akre
David Einhorn
Tom Gayner
My Guru Lists
Insiders
Insider Trading Tracker
Real-Time Insider Picks
CEO Buys/Sells
CFO Buys/Sells
Insider Trends
Insider Cluster
Guru + Insider Double Buys
Triple Buys/Sells
Chinese Insider
German Insider
Complete Insider List
Politician Trading Tracker
Real-Time Politician Picks
Complete Politician List
Nancy Pelosi
Mitch Mcconnell
Tommy Tuberville
Josh Gottheimer
Kevin Hern
Thomas R. Carper
Susie Lee
Lois Frankel
Market
US Market Valuation
Buffett Indicator
U.S. Treasury Yield Curve
U.S. Inflation Rate
Presidential Cycle and Stock Market
Shiller P/E
Shiller P/E by Sectors
GF Value for S&P 500 Index
Fed Net Liquidity
Buffett Assets Allocation
Latest IPOs
Global Market Valuation
Global Market Overview
USA
China
Japan
India
Canada
UK
France
Germany
Brazil
Australia
More...
Economic Indicators
Economic Indicators Overview
The Dow Jones Industrial Average (DJIA)
SP 500 Index
Nasdaq Composite Index
Gross Domestic Product (GDP)
Shiller PE
Ratio of Wilshire 5000 over GNP
Civilian Unemployment Rate
Russell 2000 Index
CBOE Volatility Index (VIX)
Total Nonfarm Payrolls: All Employees
More...
Sector & Industry Performance
Global Industry Overview
USA
Asia
Europe
Canada
UK/Ireland
Oceania
Latin America
Africa
India/Pakistan
Articles
Articles
Editors' Picks
Stock Market News
Q&A with Gurus
Guru Stock Picks
Insider Transaction
Earning Reports
CEO Shareholder Letters
Podcast
Earnings Call Transcripts
Software Stock News
Biotechnology Stock News
Hardware Stock News
Banks Stock News
Metals & Mining Stock News
Drug Manufacturers Stock News
All Articles
Submit Articles
Submit Article Online
Contributor Guidelines
Tools
Model Portfolios
All-In-One Screener
Data Batch Download
Guru Portfolio Download
Insider Data Download
Excel Add-In
Google Sheets Add-On
API
Manual of Stocks
DCF Calculator
WACC Calculator
Interactive Chart
Maps
Fund Letters Archive
Stock Comparison Table
Mobile App
Discussion Board
GuruGPT
Financial Calendar
Embed Widgets
Stock Market Holidays
Discussion
Discussion Board
GuruFocus Discord
ETF
Data
Pricing
Tutorials
Tutorials
Financial Glossary
FAQ
Change Log
Contact Us
Support
Chat Support
Create a ticket
Book Demo
User Engagement Meeting
469-248-6885
Status
Take Survey
Ask the community in Discord
Subscribe
Free Trial
Group Subscription
Refer a Friend and Earn One Month of Free Membership
GURUFOCUS.COM
STOCK LIST
Healthcare
Biotechnology
Cerevel Therapeutics Holdings Inc (NAS:CERE)
News
Cerevel Therapeutics Holdings Inc
1
1
NAS
:CERE (USA) Â
Ordinary Shares
$ 41.99
-0.11 (-0.26%)
10:09 PM EST
P/E:
At Loss
P/B:
11.29
Market Cap:
$ 7.62B
Enterprise V:
$ 7.02B
Volume:
1.31M
Avg Vol (2M):
1.23M
Warning! GuruFocus detected 1 Severe warning sign with CERE.
Try a 7-Day Free Trial
to check it out.
Also Trade In:
Volume:
1.31M
Market Cap $:
7.62B
PE Ratio:
At Loss
Avg Vol (2M):
1.23M
Enterprise Value $:
7.02B
PB Ratio:
11.29
Alerts
Website
SEC Filings
Stock PDF
Dataset
Financial Download
Manual of Stocksâ„¢
Compare
0
Summary
30-Y Financials
Estimates
DCF
Dividend
Guru Trades
Insider
Interactive Chart
Filings
Transcripts
News
Compare
Stock PDF
Ownership
Operating
Checklist
Vote
Definitions
Cerevel Therapeutics Holdings Inc (NAS:CERE) Stock News, Headlines & Updates
Cerevel Therapeutics Holdings Inc Stock News from GuruFocus
Total 98
1
2
3
Apr 18, 2024
Cerevel Therapeutics Announces Positive Topline Results for Tavapadon in Phase 3 Adjunctive Trial for People Living with Parkinson's Disease
Marketwired
•
6:00am
Apr 03, 2024
Director N Coles Sells 50,000 Shares of Cerevel Therapeutics Holdings Inc (CERE)
GuruFocus Research
•
5:01pm
Mar 07, 2024
Director N Coles Sells 50,000 Shares of Cerevel Therapeutics Holdings Inc (CERE)
GuruFocus Research
•
10:28pm
Mar 02, 2024
Abbvie Inc To Acquire Cerevel Therapeutics Transcript
GuruFocus Research
•
7:26pm
Q3 2023 Cerevel Therapeutics Holdings Inc Earnings Call Transcript
GuruFocus Research
•
7:26pm
Cerevel Therapeutics Holdings Inc at Morgan Stanley Global Healthcare Conference Transcript
GuruFocus Research
•
7:26pm
Q2 2023 Cerevel Therapeutics Holdings Inc Earnings Call Transcript
GuruFocus Research
•
7:26pm
Cerevel Therapeutics Holdings Inc at Bank of America Global Healthcare Conference Transcript
GuruFocus Research
•
7:26pm
Q1 2023 Cerevel Therapeutics Holdings Inc Earnings Call Transcript
GuruFocus Research
•
7:26pm
Cerevel Therapeutics Holdings Inc at Stifel CNS Days (Virtual) Transcript
GuruFocus Research
•
7:26pm
Cerevel Therapeutics Holdings Inc at Cowen Health Care Conference Transcript
GuruFocus Research
•
7:26pm
Q4 2022 Cerevel Therapeutics Holdings Inc Earnings Call Transcript
GuruFocus Research
•
7:26pm
Cerevel Therapeutics Holdings Inc at JPMorgan Healthcare Conference Transcript
GuruFocus Research
•
7:26pm
Q3 2022 Cerevel Therapeutics Holdings Inc Earnings Call Transcript
GuruFocus Research
•
7:26pm
Cerevel Therapeutics Holdings Inc at Morgan Stanley Global Healthcare Conference Transcript
GuruFocus Research
•
7:26pm
Q2 2022 Cerevel Therapeutics Holdings Inc Earnings Call Transcript
GuruFocus Research
•
7:26pm
Q1 2022 Cerevel Therapeutics Holdings Inc Earnings Call Transcript
GuruFocus Research
•
7:26pm
Cerevel Therapeutics Holdings Inc at Morgan Stanley Global Healthcare Conference (Virtual) Transcript
GuruFocus Research
•
7:26pm
Cerevel Therapeutics Holdings Inc at Citi BioPharma Conference (Virtual) Transcript
GuruFocus Research
•
7:26pm
Cerevel Therapeutics Holdings Inc R&D Event Transcript
GuruFocus Research
•
7:26pm
Jan 24, 2024
Kuehn Law Encourages MDC, WAVD, NS and CERE Investors to Contact Law Firm
PRNewswire
•
8:00am
Jan 23, 2024
SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates CSTR, SIX, CERE, EGLE
PRNewswire
•
2:00pm
Jan 08, 2024
CERE Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Cerevel Therapeutics Holdings, Inc. Is Fair to Shareholders
Business Wire
•
12:00pm
Jan 03, 2024
Kuehn Law Encourages CERE, HA, IMGN, and WAVD Investors to Contact Law Firm
PRNewswire
•
6:00pm
Dec 29, 2023
Chief Medical Officer Ramiro Sanchez Sells 10,000 Shares of Cerevel Therapeutics Holdings Inc
GuruFocus Research
•
2:02pm
Dec 28, 2023
STOCKHOLDER ALERT: The M&A Class Action Firm Continues Investigating the Merger - CERE, WAVD, ICVX, EAR
PRNewswire
•
8:00pm
Dec 27, 2023
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BVH, CERE, ICVX, RAIN
PRNewswire
•
11:00pm
Dec 23, 2023
Insider Sell: Cerevel Therapeutics Holdings Inc's Chief Human Resources Officer Sells Company Shares
GuruFocus Research
•
10:13pm
Dec 19, 2023
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CERE, EGLE, ICVX, RAIN
PRNewswire
•
6:00pm
Dec 12, 2023
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CERE, IMGN, ROVR, GRPH
PRNewswire
•
12:00pm
Dec 09, 2023
ALERT: Juan Monteverde Encourages the Shareholders of CERE, PFIN, NWLI, CSTR to Take Action
PRNewswire
•
8:00pm
Dec 08, 2023
CEREVEL THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Cerevel Therapeutics - CERE
Business Wire
•
4:00pm
Insider Sell Alert: Cerevel Therapeutics Holdings Inc's Chief Legal Officer Scott Akamine Sells 17,500 Shares
GuruFocus Research
•
4:05am
Dec 07, 2023
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CERE, SLGC, LAB
PRNewswire
•
12:00pm
Shareholder Alert: Ademi LLP investigates whether Cerevel Therapeutics has obtained a Fair Price in its transaction with AbbVie
PRNewswire
•
11:00pm
CERE MERGER ANNOUNCEMENT: Julie & Holleman LLP Announces Investigation Into Potential Claims Regarding AbbVie's Proposed Acquisition of Cerevel Therapeutics
PRNewswire
•
11:00pm
CERE Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Cerevel Therapeutics Holdings, Inc. Is Fair to Shareholders
Business Wire
•
7:00pm
Nov 17, 2023
Insider Sell Alert: Director N Coles Sells 22,824 Shares of Cerevel Therapeutics Holdings Inc (CERE)
GuruFocus Research
•
10:17pm
Nov 07, 2023
Director N Coles Sells 100,000 Shares of Cerevel Therapeutics Holdings Inc (CERE)
GuruFocus Research
•
12:02am
Nov 04, 2023
Director Deval Patrick Sells 30,130 Shares of Cerevel Therapeutics Holdings Inc (CERE)
GuruFocus Research
•
9:44pm
Total 98
1
2
3
Show
20
40
60
80
100
No data
Entries
Headlines
Total 0
1
No recent news